Denice D. Tsao-Wei - Keck School of Medicine and Children's Hospital Los Angeles, University of Southern California

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 187 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Immune Modulation During Treatment with Enzalutamide Alone or with Radium-223 in Patients with Castration Resistant Prostate Cancer

Peter D Zang,Diane M Da Silva,Zhang-Xu Liu, Shivani Kandukuri,Denice Tsao-Wei, Anishka D'Souza,W Martin Kast, Sumanta K Pal,Cheryl Kefauver, Maribel Juanqueira, Lixin Yang, David I Quinn, Tanya B Dorff

Cancers（2025）

Cited0Views0WOSBibtex

Improved Efficacy of Pembrolizumab Combined with Soluble EphB4-albumin in HPV-negative EphrinB2 Positive Head Neck Squamous Cell Carcinoma

Alexandra Jackovich,Barbara J Gitlitz,Justin Wayne Wong Tiu-Lim,Vinay Duddalwar,Kevin George King,Anthony B El-Khoueiry,Jacob Stephen Thomas,Denice Tsao-Wei,David I Quinn,Parkash S Gill,Jorge J Nieva

Oncotarget (2024): 444-458

Cited0Views0WOSBibtex

1997P Novel Biomarker, Ephrinb2 (B2), Predicts Resistance to Treatment and Poor Overall Survival (OS) Metastatic Urothelial Carcinoma (Muc)

S. Sadeghi,N. Mar,D. Tsao-Wei,I. Siddiqi,D. Freeman, K. Torkko, A. van Bokhoven,T. Flaig, P. Gill,A. Rezazadeh Kalebasty,G.P. Sonpavde,J. Bellmunt

Annals of Oncology (2024): S1155

Cited0Views0Bibtex

1697P Phase II Randomized Double-Blind Trial of Axitinib (axi) +/- PF 04518600, an OX40 Antibody (PFOX) after PD1/PDL1 Antibody (IO) Therapy (tx) in Metastatic Renal Cell Carcinoma (mrcc): Final Analysis

S. Sadeghi, R. Parikh,L.J. Appleman,D. Tsao-Wei,S. Groshen, M. Li,S.T. Tagawa,D.M. Nanus, A.M. Molina,M.C. Ornstein,B.I. Rini,R. Dreicer,D.I. Quinn,P.N. Lara

Annals of Oncology（2024）

Cited0Views0Bibtex

Association of Ephrinb2 (B2) Expression on Overall Survival (OS) and Resistance to PD1/L1 Inhibitors (inh) in Metastatic Urothelial Carcinoma (Muc)

Sarmad Sadeghi,Nataliya Mar,Denice Tsao-Wei,Karam Ashouri,Imran Siddiqi, Jon P. Cogan,Alexandra Jackovich,Dory Freeman,Jillian O'Toole,Thomas W. Flaig,Parkash S. Gill,Arash Rezazadeh,Guru P. Sonpavde,Joaquim Bellmunt

Journal of Clinical Oncologyno. 16_suppl (2024): 4577-4577

Cited0Views0Bibtex

Efficacy from the Phase 1 Study of FID-007, a Novel Nanoparticle Paclitaxel Formulation, in Patients with Head and Neck Squamous Cell Carcinoma

Lydia D. Chow,Robert Hsu,Jorge J. Nieva,Rebecca Umayam, Angela Smith Bryant,Denice Tsao-Wei, Ming Hsieh,Ray Yin,Anthony B. El-Khoueiry,Jacob Stephen Thomas

Journal of Clinical Oncologyno. 16_suppl (2024): 6042-6042

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn